Imricor Medical Systems, Inc. (ASX:IMR)

Market Cap	435.25M
Revenue (ttm)	1.55M
Net Income (ttm)	-47.98M
Shares Out	270.34M
EPS (ttm)	-0.21
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	402,736
Average Volume	416,793
Open	1.740
Previous Close	1.610
Day's Range	1.660 - 1.740
52-Week Range	0.410 - 1.855
Beta	-0.28
RSI	55.62
Earnings Date	Apr 29, 2025

About Imricor Medical Systems

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company’s product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to min...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Country: United States
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: IMR

Financial Performance

In 2024, Imricor Medical Systems's revenue was $959,424, an increase of 55.86% compared to the previous year's $615,568. Losses were -$29.69 million, 31.2% more than in 2023.

Financial numbers in USD